GTSO: Transdermal Patch Market Projected to Reach $40 Billion

SAN JOSE, Calif.--()--As Green Technology Solutions develops a new transdermal patch for the medical cannabis industry, a leading industry source reports that the market for transdermal drug delivery could be worth as much as $40 billion by 2018.

The projection comes from Healthcare Packaging, a leading industry source for information on packaging and logistics for pharmaceuticals, biologics, medical devices and nutraceuticals. The publication also reported that transdermal patch delivery had a market of $25 billion last year.

NTRR is working on a new product to expand that market to cannabis consumers. Transdermal patches comprise a new way to consume cannabis: through the skin. Working on much the same principle as more common nicotine or birth-control patches, cannabis patches can be applied directly to various parts of the body, where they deliver a slow and controlled release of cannabinoids.

“Many different kinds of patients love receiving treatment via transdermal patch, because patches are comfortable, discrete and predictable,” said GTSO CEO Wallace W. Browne. “Our company believes that the transdermal patch allows for the ideal delivery of cannabinoids, and we think that cannabis patients around the country will soon agree.”

GTSO is dedicated to bringing new product ideas such as the transdermal patch to market in regulated cannabis industries across North America. The company recently formed a joint venture with Elevated Industries—a Canada-based company poised to become a dominant supplier of cannabis-based edible recipes in the booming North American marketplace. The company creates and licenses edible recipes that are available in jurisdictions where the sale of cannabis-based products is legal.

As the global market for cannabis continues to grow, GTSO plans to keep delivering new tools like the transdermal patch to help wholesalers and retailers guarantee their edible products’ potency, consistency and safety to their customers.

About Green Technology Solutions, Inc.

Green Technology Solutions, Inc., which provides business support, delivery system products and horticultural technology support, continually introduces new products and services, enabling it to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC) and others in a booming industry expected to be $10 billion by 2018. A growth-oriented company, Green Technology Solutions Inc. (GTSO) explores the fast-growing cannabis market for resources, including but not limited to rare earth elements, precious metals and herbal supplements. For more information, visit www.gtsoresources.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts

Green Technology Solutions, Inc.
Wallace W. Browne, 408-432-7285
President and CEO
info@gtsoresources.com

Release Summary

GTSO: Transdermal Patch Market Projected to Reach $40 Billion

Contacts

Green Technology Solutions, Inc.
Wallace W. Browne, 408-432-7285
President and CEO
info@gtsoresources.com